HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xuelai Luo Selected Research

Class Ia Phosphatidylinositol 3-Kinase

8/2020PIK3R3 regulates ZO-1 expression through the NF-kB pathway in inflammatory bowel disease.
1/2018PIK3R3 promotes chemotherapeutic sensitivity of colorectal cancer through PIK3R3/NF-kB/TP pathway.
1/2013p55PIK transcriptionally activated by MZF1 promotes colorectal cancer cell proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xuelai Luo Research Topics

Disease

20Neoplasms (Cancer)
01/2022 - 05/2005
13Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 04/2012
6Neoplasm Metastasis (Metastasis)
01/2022 - 06/2011
5Carcinogenesis
01/2021 - 10/2013
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2018 - 01/2016
3Retinoblastoma (Glioblastoma, Retinal)
06/2015 - 01/2013
2Colonic Neoplasms (Colon Cancer)
01/2013 - 04/2012
2Stomach Neoplasms (Stomach Cancer)
06/2011 - 05/2005
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2020
1Pathologic Processes
01/2020
1Hypoxia (Hypoxemia)
10/2019
1Non-alcoholic Fatty Liver Disease
01/2018
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2018
1Fatty Liver
01/2018
1Pathologic Neovascularization
11/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017
1Heart Diseases (Heart Disease)
11/2016
1Adenocarcinoma of Lung
06/2015
1Breast Neoplasms (Breast Cancer)
11/2012
1Genomic Instability
06/2011
1Lymphatic Metastasis
06/2011
1Carcinoma (Carcinomatosis)
05/2005

Drug/Important Bio-Agent (IBA)

4Histones (Histone)IBA
01/2021 - 06/2011
4Proteins (Proteins, Gene)FDA Link
11/2016 - 06/2011
4Protein Isoforms (Isoforms)IBA
06/2015 - 07/2013
3Peptides (Polypeptides)IBA
01/2022 - 12/2008
3Lysine (L-Lysine)FDA Link
01/2021 - 09/2016
3Histone MethyltransferasesIBA
01/2021 - 09/2016
3Class Ia Phosphatidylinositol 3-KinaseIBA
08/2020 - 01/2013
3Histone DemethylasesIBA
01/2020 - 01/2018
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2018 - 05/2005
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 01/2013
3Pharmaceutical PreparationsIBA
11/2017 - 07/2013
3Phosphatidylinositols (Phosphatidylinositol)IBA
06/2015 - 04/2012
2CytokinesIBA
01/2021 - 06/2011
2NF-kappa B (NF-kB)IBA
08/2020 - 01/2018
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1Cetuximab (Erbitux)FDA Link
01/2020
1Calcibiotic Root Canal SealerIBA
01/2020
1Vascular Endothelial Growth FactorsIBA
10/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2019
1Hypoxia-Inducible Factor 1IBA
10/2019
1MicroRNAs (MicroRNA)IBA
01/2019
13,4-methylenedioxyethamphetamine (MDEA)IBA
01/2019
1Biomarkers (Surrogate Marker)IBA
12/2018
1Sirtuin 2IBA
12/2018
1GalactosidasesIBA
12/2018
1Fluorouracil (Carac)FDA LinkGeneric
01/2018
1Fatty Acids (Saturated Fatty Acids)IBA
01/2018
1Gefitinib (Iressa)FDA Link
01/2017
1Tyrosine Kinase InhibitorsIBA
01/2017
1Adenosine Triphosphatases (ATPase)IBA
01/2017
1Sucrose (Saccharose)IBA
01/2017
1Sirtuin 1IBA
01/2017
1ErbB Receptors (EGF Receptor)IBA
01/2017
1Imatinib Mesylate (Gleevec)FDA Link
01/2016
1Transforming Growth Factors (Transforming Growth Factor)IBA
06/2015
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
06/2015
1DNA (Deoxyribonucleic Acid)IBA
10/2013
1Retinoblastoma ProteinIBA
01/2013
1protoapigenoneIBA
11/2012
12- (1- hydroxy- 4- oxocyclohexa- 2,5- dienyl)pyran- 4- oneIBA
11/2012
1Small Interfering RNA (siRNA)IBA
04/2012
1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2012
1ChromatinIBA
06/2011
1CC ChemokinesIBA
06/2011
1N 30IBA
06/2011
1Chemokine CCL5IBA
06/2011
1CCR5 Receptors (CCR5 Receptor)IBA
06/2011
1Bromodeoxyuridine (BrdU)IBA
05/2005

Therapy/Procedure

10Therapeutics
01/2021 - 12/2008
2Drug Therapy (Chemotherapy)
01/2021 - 05/2005